Models of gender differences in cardiovascular disease

Drug Discovery Today: Disease Models

Volumn 4, Issue 4, 2007, Pages 227-232

  Patten, Richard D ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ATRIAL NATRIURETIC FACTOR; ESTROGEN; ESTROGEN RECEPTOR; GELATINASE B; MYOSIN HEAVY CHAIN BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C EPSILON; SEX HORMONE;

ABDOMINAL AORTA ANEURYSM; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CHOLESTEROL DIET; CLINICAL OBSERVATION; CONGESTIVE CARDIOMYOPATHY; DISEASE ASSOCIATION; DISEASE MODEL; DISEASE SEVERITY; DRUG RESEARCH; DRUG TARGETING; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE INJURY; HEART VENTRICLE REMODELING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MACACA; MALE; MENOPAUSE; MYOCARDIAL DISEASE; NONHUMAN; OUTCOME ASSESSMENT; PREVALENCE; PROGNOSIS; RABBIT; REVIEW; SEX DIFFERENCE;

EID: 46749096770     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2007.11.002     Document Type: Review

References (42)

1. American Heart Association. Heart Disease and Stroke Statistics: 2005 Statistical Supplement (2005), American Heart Association, Dallas, TX pp. 1-60
2. Lerner D.J., and Kannel W.B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am. Heart J. 111 (1986) 383-390
3. O'Meara E., et al. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program. Circulation 115 (2007) 3111-3120
4. Hayward C.S., et al. The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc. Res. 46 (2000) 28-49
5. Carroll J.D., et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 86 (1992) 1099-1107
6. Douglas P.S., et al. Gender differences in left ventricle geometry and function in patients undergoing balloon dilatation of the aortic valve for isolated aortic stenosis. NHLBI Balloon Valvuloplasty Registry. Br. Heart J. 73 (1995) 548-554
7. Krumholz H.M., et al. Sex differences in cardiac adaptation to isolated systolic hypertension. Am. J. Cardiol. 72 (1993) 310-313
8. Rohde L.E., et al. Gender-associated differences in left ventricular geometry in patients with aortic valve disease and effect of distinct overload subsets. Am. J. Cardiol. 80 (1997) 475-480
9. Wexler B.C., and Miller B.F. Severe arteriosclerosis and other diseases in the rat produced by corticotrophin. Science 127 (1958) 590-591
10. Hamm Jr. T.E., et al. Effects of gender and social behavior on the development of coronary artery atherosclerosis in cynomolgus macaques. Atherosclerosis 48 (1983) 221-233
11. Adams M.R., et al. Ovariectomy, social status, and atherosclerosis in cynomolgus monkeys. Arteriosclerosis 5 (1985) 192-200
12. Hayashi T., et al. Gender differences in atherosclerosis: possible role of nitric oxide. J. Cardiovasc. Pharmacol. 26 (1995) 792-802
13. Hayashi T., et al. Modulating role of estradiol on arginase II expression in hyperlipidemic rabbits as an atheroprotective mechanism. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 10485-10490
14. Moroi M., et al. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J. Clin. Invest. 101 (1998) 1225-1232
15. Tolbert T., et al. Estrogen-induced vasoprotection is independent of inducible nitric oxide synthase expression: evidence from the mouse carotid artery ligation model. Circulation 104 (2001) 2740-2745
16. Akishita M., et al. Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells. Atherosclerosis 130 (1997) 1-10
17. Chen S.-J., et al. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 93 (1996) 577-584
18. Ailawadi G., et al. Gender differences in experimental aortic aneurysm formation. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 2116-2122
19. Sinha I., et al. Female gender attenuates cytokine and chemokine expression and leukocyte recruitment in experimental rodent abdominal aortic aneurysms. Ann. N. Y. Acad. Sci. 1085 (2006) 367-379
20. Bakir S., et al. Estrogen-induced vasoprotection is estrogen receptor dependent: evidence from the balloon-injured rat carotid artery model. Circulation 101 (2000) 2342-2344
21. Murphy E., and Steenbergen C. Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 75 (2007) 478-486
22. Bae S., and Zhang L. Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts: focus on Akt and protein kinase C signaling. J. Pharmacol. Exp. Ther. 315 (2005) 1125-1135
23. Brown D.A., et al. Susceptibility of the heart to ischaemia-reperfusion injury and exercise-induced cardioprotection are sex-dependent in the rat. J. Physiol. 564 (2005) 619-630 Epub 2005 February 17
24. Wang M., et al. Estrogen receptor-alpha mediates acute myocardial protection in females. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H2204-H2209
25. Przyklenk K., et al. Gender does not influence acute myocardial infarction in adult dogs. Am. Heart J. 129 (1995) 1108-1113
26. Cavasin M.A., et al. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. Life Sci. 75 (2004) 2181-2192
27. van Eickels M., et al. 17-Beta-estradiol increases cardiac remodeling and mortality in mice with myocardial infarction. J. Am. Coll. Cardiol. 41 (2003) 2084-2092
28. Tamura T., et al. Gender-related differences in myocyte remodeling in progression to heart failure. Hypertension 33 (1999) 676-680
29. Douglas P.S., et al. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J. Am. Coll. Cardiol. 32 (1998) 1118-1125
30. Weinberg E.O., et al. Gender differences in molecular remodeling in pressure overload hypertrophy. J. Am. Coll. Cardiol. 34 (1999) 264-273
31. Brower G.L., et al. Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomy. Mol. Cell. Biochem. 251 (2003) 89-95
32. Gardner J.D., et al. Gender differences in cardiac remodeling secondary to chronic volume overload. J. Card. Fail. 8 (2002) 101-107
33. Dash R., et al. Differential regulation of p38 mitogen-activated protein kinase mediates gender-dependent catecholamine-induced hypertrophy. Cardiovasc. Res. 57 (2003) 704-714
34. Kadokami T., et al. Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. J. Clin. Invest. 106 (2000) 589-597
35. Gao X.-M., et al. Sex hormones and cardiomyopathic phenotype induced by cardiac {beta}2-adrenergic receptor overexpression. Endocrinology 144 (2003) 4097-4105
36. Xiong S., et al. Loss of Mdm4 results in p53-dependent dilated cardiomyopathy. Circulation 115 (2007) 2925-2930
37. Bridgman P., et al. Gender-specific patterns of left ventricular and myocyte remodeling following myocardial infarction in mice deficient in the angiotensin II type 1a receptor. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H586-H592
38. Holm P., et al. Gender gap in aortic cholesterol accumulation in cholesterol-clamped rabbits: role of the endothelium and mononuclear-endothelial cell interaction. Circulation 98 (1998) 2731-2737
39. Johnson M.S., et al. Sex differences in myocardial infarct size are abolished by sarcolemmal KATP channel blockade in rat. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H2644-H2647
40. Forman D.E., et al. Cardiac morphology and function in senescent rats: gender-related differences. J. Am. Coll. Cardiol. 30 (1997) 1872-1877
41. Skavdahl M., et al. Estrogen receptor-{beta} mediates male-female differences in the development of pressure overload hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H469-H476
42. Olsson M.C., et al. Gender and aging in a transgenic mouse model of hypertrophic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H1136-H1144